Should Patients with Autosomal Dominant Polycystic Kidney Disease Be Screened for Cerebral Aneurysms?

REFERENCES

1. 1.↵
   1. Dalgaard OZ

   . Bilateral polycystic disease of the kidneys: a follow-up of 284 patients and their families. Acta Med Scan Suppl 1957;328:1–255
2. 2.↵
   1. Wilson P

   . Polycystic kidney disease. N Engl J Med 2004;350:151–64

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Obuchowski NA,
   2. Graham RJ,
   3. Baker ME,
   4. et al

   . Ten criteria for effective screening: their application to multislice CT screening for pulmonary and colorectal cancers. AJR Am J Roentgenol 2001;176:1357–62

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Black WC,
   2. Welch HG

   . Screening for disease. AJR Am J Roentgenol 1997;168:3–11

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Schievink WI,
   2. Torres VE,
   3. Piepgras DG,
   4. et al

   . Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1992;3:88–95

   Abstract
6. 6.↵
   1. Chapman AB,
   2. Rubinstein D,
   3. Hughes R,
   4. et al

   . Intracranial aneuryms in autosomal dominant polycystic kidney disease. N Engl J Med 1992;327:916–20

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Huston J 3rd.,
   2. Torres VE,
   3. Sulivan PP,
   4. et al

   . Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1993;3:1871–77

   Abstract
8. 8.↵
   1. Rinkel GJ,
   2. Djibuti M,
   3. Algra A,
   4. et al

   . Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998;29:251–56

   Abstract/FREE Full Text
9. 9.↵
   1. Ruggieri PM,
   2. Poulos N,
   3. Masaryk TJ,
   4. et al

   . Occult intracranial aneurysms in polycystic kidney disease: Screening with MR angiography. Radiology 1994;191:33–39

   PubMedWeb of Science
10. 10.↵
    1. Graf S,
    2. Schischma A,
    3. Eberhardt KE,
    4. et al

    . Intracranial aneurysms and dolichoectasia in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2002;17:819–23

    Abstract/FREE Full Text
11. 11.↵
    1. Wakabayashi T,
    2. Fujita S,
    3. Ohbora Y,
    4. et al

    . Polycystic kidney disease and intracranial aneurysms. J Neurosurg 1983;58:488–91

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Chauveau D,
    2. Pirson Y,
    3. Verellen-Dumoulin C,
    4. et al

    . Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 1994;45:1140–46

    CrossRefPubMedWeb of Science
13. 13.↵
    1. de la Monte SM,
    2. Moore GW,
    3. Monk MA,
    4. et al

    . Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med 1985;78:957–64

    CrossRefPubMed
14. 14.↵
    1. Inagawa T,
    2. Hirano A

    . Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol 1990;34:361–65

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Fox JL

    , ed. Intracranial Aneurysms. New York: Springer-Verlag; 1983:15–18
16. 16.↵
    1. Stehbens WE

    . Pathology of the Cerebral Blood Vessels. St. Louis: Mosby; 1972:351–470
17. 17.↵
    1. Fick GM,
    2. Johnson AM,
    3. Hammond WS,
    4. et al

    . Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995;5:2048–56

    Abstract
18. 18.↵
    1. Fick GM,
    2. Gabow PA

    . Hereditary and acquired cystic disease of the kidney. Kidney Int 1994;46:951

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Xu HW,
    2. Yu SQ,
    3. Mei CL,
    4. et al

    . Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 2011;42:204–06

    Abstract/FREE Full Text
20. 20.↵
    1. Wiebers DO,
    2. Wisnant JP,
    3. Juston J 3rd.,
    4. et al

    . International Study of Unruptured Intracranial Aneurysms investigators: unruptured intracranial aneurysms—natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103–10

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Wiebers DO,
    2. Whisnant JP,
    3. Sundt TM,
    4. et al

    . The significance of unruptured intracranial saccular aneurysms. J Neurosurg 1987;66:23–29

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Wiebers DO,
    2. Piepgras DG,
    3. Meyer FB,
    4. et al

    . Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms. Mayo Clin Proc 2004;79:1572–83

    CrossRefPubMed
23. 23.↵
    1. Matsubara S,
    2. Hadeishi H,
    3. Suzuki A,
    4. et al

    . Incidence and risk factors for the growth of unruptured cerebral aneurysms: observation using serial computerized tomography angiography. J Neurosurg 2004;101:908–14

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Burns JD,
    2. Huston J 3rd.,
    3. Layton KF,
    4. et al

    . Intracranial aneurysm enlargement on serial magnetic resonance angiography: frequency and risk factors. Stroke 2009;40:406–11

    Abstract/FREE Full Text
25. 25.↵
    1. Gibbs G,
    2. Huston J,
    3. Qian Q,
    4. et al

    . Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney International 2004;65:1621–27

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Schrier R,
    2. Belz M,
    3. Johnson A,
    4. et al

    . Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up. J Am Soc Nephrol 2004;15:1023–28

    Abstract/FREE Full Text
27. 27.↵
    1. Hop JW,
    2. Rinkel GJ,
    3. Algra A,
    4. et al

    . Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28:660–64

    Abstract/FREE Full Text
28. 28.↵
    1. Lozano AM,
    2. Leblanc R

    . Cerebral aneurysms and polycystic kidney disease: a critical review. Can J Neurol Sci 1992;19:222–27

    PubMedWeb of Science
29. 29.↵
    1. Chapman AB,
    2. Johnson AM,
    3. Gabow PA

    . Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen. Am J Kidney Dis 1993;22:526–31

    PubMed
30. 30.↵
    Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 2000;31:1843–50

    Abstract/FREE Full Text
31. 31.↵
    1. Chauveau D,
    2. Pirson Y,
    3. Verellen-Dumoulin C,
    4. et al

    . Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 1994;45:1140

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Bichet D,
    2. Peters D,
    3. Patel AJ,
    4. et al

    . Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models. Trends Cardiovasc Med 2006;16:292–98

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Kip SN,
    2. Hunter LW,
    3. Ren Q,
    4. et al

    . [Ca21]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype. Circ Res 2005;96:873–80

    Abstract/FREE Full Text
34. 34.↵
    1. Hassane S,
    2. Claij N,
    3. Lantinga-van Leeuwen IS,
    4. et al

    . Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse model. Arterioscler Thromb Vasc Biol 2007;27:2177–83

    Abstract/FREE Full Text
35. 35.↵
    1. Rossetti S,
    2. Chauveau D,
    3. Kubly V,
    4. et al

    . Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 2003;361:2196

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Hiratsuka Y,
    2. Miki H,
    3. Kiriyama I,
    4. et al

    . Diagnosis of unruptured intracranial aneurysms: 3T MR angiography vs. 64-channel multi-detector row CT angiography. Magn Reson Med Sci 2008;7:169–78

    CrossRefPubMed
37. 37.↵
    1. Chauveau D,
    2. Pirson Y,
    3. Verellen-Dumoulin C,
    4. et al

    . Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 1994;45:1140

    CrossRefPubMedWeb of Science
38. 38.↵
    1. van Gelder JM

    . Computed tomographic angiography for detecting cerebral aneurysms: implications of aneurysm size distribution for the sensitivity, specificity, and likelihood ratios. Neurosurgery 2003;53:597–605, discussion 605–06

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Villablanca J,
    2. Jahan R,
    3. Hooshi P,
    4. et al

    . Detection and characterization of very small cerebral aneurysms by using 2D and 3D helical CT angiography. AJNR Am J Neuroradiol 2002;23:1187–98

    Abstract/FREE Full Text
40. 40.↵
    1. Willinsky RA,
    2. Taylor SM,
    3. TerBrugge K,
    4. et al

    . Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 2003;227:522–28

    CrossRefPubMedWeb of Science
41. 41.↵
    ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media, Version 8. Reston, Virginia: American College of Radiology; 2012
42. 42.↵
    1. Mnyusiwalla A,
    2. Aviv R,
    3. Symons S

    . Radiation dose from multidetector row CT imaging for acute stroke. Neuroradiology 2009;51:635–40

    CrossRefPubMedWeb of Science
43. 43.↵
    RadiologyInfo.org. Radiological Society of North America. What are x-rays and what do they do? 2012. http://www.radiologyinfo.org/en/pdf/sfty_xray.pdf. Accessed September 1, 2012
44. 44.↵
    1. Brinjikji W,
    2. Rabinstein A,
    3. Nasr D,
    4. et al

    . Better outcomes with treatment by coiling relative to clipping of unruptured intracranial aneurysms in the United States, 2001–2008. AJNR Am J Neuroradiol 2011;32:1071–75

    Abstract/FREE Full Text
45. 45.↵
    1. Alshekhlee A,
    2. Mehta S,
    3. Edgell RC,
    4. et al

    . Hospital mortality and complications of electively clipped or coiled unruptured intracranial aneurysm. Stroke 2010;41:1471–76

    Abstract/FREE Full Text
46. 46.↵
    1. Pierot L,
    2. Spelle L,
    3. Vitry F

    . Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: results of the ATENA study. Stroke 2008;39:2497–504

    Abstract/FREE Full Text
47. 47.↵
    1. Renowden SA,
    2. Koumellis P,
    3. Benes V,
    4. et al

    . Retreatment of previously embolized cerebral aneurysms: the risk of further coil embolization does not negate the advantage of the initial embolization. AJNR Am J Neuroradiol 2008;29:1401–04

    Abstract/FREE Full Text
48. 48.↵
    1. Juvela S

    . Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke 2003;34:1852–57

    Abstract/FREE Full Text
49. 49.↵
    1. Rinkel G,
    2. Prins N,
    3. Algra A

    . Outcome of aneurysmal subarachnoid hemorrhage in patients on anticoagulant treatment. Stroke 1997;28:6–9

    Abstract/FREE Full Text
50. 50.↵
    1. Wardlaw J,
    2. White P

    . The detection and management of unruptured intracranial aneurysms. Brain 2000;123:205–21

    Abstract/FREE Full Text
51. 51.↵
    1. Crawley F,
    2. Clifton A,
    3. Brown M

    . Should we screen for familial intracranial aneurysm? Stroke 1999;30:312–16

    Abstract/FREE Full Text
52. 52.↵
    1. Takao H,
    2. Nojo T

    . Treatment of unruptured intracranial aneurysms: decision and cost effectiveness analysis. Radiology 2007;244:755–66

    CrossRefPubMedWeb of Science
53. 53.↵
    1. Butler W,
    2. Barker F,
    3. Crowell R

    . Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis. Neurosurgery 1996;38:506–15, discussion 515–16

    CrossRefPubMedWeb of Science
54. 54.↵
    1. Mitchell P,
    2. Gholkar A,
    3. Vindlacheruvu R,
    4. et al

    . Unruptured intracranial aneurysms: benign curiosity or ticking bomb? Lancet Neurol 2004;3:85–92

    CrossRefPubMedWeb of Science
55. 55.↵
    1. Brinjikji W,
    2. Kallmes D,
    3. Lanzino G,
    4. et al

    . Hospitalization costs for endovascular and surgical treatment of ruptured aneurysms in the United States are substantially higher than Medicare payments. AJNR Am J Neuroradiol 2012;33:1037–40

    Abstract/FREE Full Text
56. 56.↵
    1. Laupacis A,
    2. Feeny D,
    3. Detsky A,
    4. et al

    . How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146:473–81

    Abstract
57. 57.↵
    1. Johnston SC,
    2. Gress DR,
    3. Kahn JG

    . Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology 1999;52:1806–15

    CrossRef
58. 58.↵
    1. Bor S,
    2. Koffjberg H,
    3. Wermer M,
    4. et al

    . Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis. Neurology 2010;74:1671–79

    CrossRef
59. 59.↵
    1. Tosteson A,
    2. Stout N,
    3. Fryback D,
    4. et al

    . Cost-effectiveness of digital mammography screening. Ann Intern Med 2008;148:1–10

    CrossRefPubMedWeb of Science
60. 60.↵
    1. Tengs TO,
    2. Adams ME,
    3. Pliskin JS,
    4. et al

    . Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995;15:369–90

    CrossRefPubMedWeb of Science
61. 61.↵
    1. Pirson Y

    . Extrarenal manifestations of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010;17:173–80

    CrossRefPubMedWeb of Science
62. 62.↵
    1. Pirson Y,
    2. Chauveau D,
    3. Torres V

    . Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2002;13:269–76

    FREE Full Text
63. 63.↵
    1. Wakai S

    . Polycystic kidneys and aneurysms. J Neurosurg 1999;90:985–86

    PubMed
64. 64.↵
    1. Torres V,
    2. Harris P,
    3. Pirson Y

    . Autosomal dominant polycystic kidney disease. Lancet 2007;369:1287–301

    CrossRefPubMedWeb of Science
65. 65.↵
    1. Morrison AS

    1. Morrison AS

    . The natural history of disease in relation to measures of disease frequency. In: Morrison AS. Screening in Chronic Disease. 2nd ed. New York: Oxford University Press; 1992:57